Form 4 for CRMD CorMedix Inc.
Accepted 2026-01-02 00:00:00 ET · period of report 2025-12-30 · accession 0001213900-26-000712 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-02 | 2025-12-30 | CRMD | DUNTON ALAN W | Dir | M - OptEx | $4.03 | +20.0K | 60.2K | +50% | +$80.6K |
| D | 2026-01-02 | 2025-12-30 | CRMD | DUNTON ALAN W | Dir | S - Sale+OE | $13.00 | -20.0K | 40.2K | -33% | -$260.0K |
| D | 2026-01-02 | 2025-12-30 | CRMD | DUNTON ALAN W | Dir | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-30 | M | A | 20,000 | $4.03 | 60,250 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-30 | S | D | 20,000 | $13.00 | 40,250 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy Common Stock) | 2025-12-30 | M | D | 20,000 | $0.00 | 0 | D | $4.03 · — to 2032-02-22 | 20,000 Common Stock | (F1) These options were granted on 2/22/2022. These options are fully vested. |